Zhai Yuewen, He Fang, Fang Ji, Li Siwen
State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 211198, China.
State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 211198, China.
Chin J Nat Med. 2024 Dec;22(12):1067-1075. doi: 10.1016/S1875-5364(24)60637-0.
Exosomes (exos), nanoscale extracellular vesicles, play a critical role in tissue development and function. Stem cell-derived exos, containing various tissue repair components, show promise as natural therapeutic agents in disease treatment and regenerative medicine. However, challenges persist in their application, particularly in targeted delivery and controlled release, which are crucial for enhancing their biological efficacy. The integration of medical devices may provide a superior platform for improving drug bioavailability. Consequently, the combination products of stem cell-derived exos and medical devices present novel opportunities for expanding the therapeutic potential of exosomes. This review offers a comprehensive overview of the current research frontier in stem cell-derived exos combined with medical devices and discusses the prospective challenges and future prospects in this field.
外泌体(exos)是纳米级的细胞外囊泡,在组织发育和功能中发挥着关键作用。干细胞衍生的外泌体含有多种组织修复成分,有望成为疾病治疗和再生医学中的天然治疗剂。然而,它们在应用中仍存在挑战,特别是在靶向递送和控释方面,这对于提高其生物学功效至关重要。医疗器械的整合可能为提高药物生物利用度提供一个优越的平台。因此,干细胞衍生的外泌体与医疗器械的组合产品为扩大外泌体的治疗潜力带来了新的机遇。本文综述全面概述了干细胞衍生的外泌体与医疗器械结合的当前研究前沿,并讨论了该领域未来面临的挑战和前景。